Martin Pomper
Martin Pomper
Verified email at
Cited by
Cited by
Transneuronal propagation of pathologic α-synuclein from the gut to the brain models Parkinson’s disease
S Kim, SH Kwon, TI Kam, N Panicker, SS Karuppagounder, S Lee, JH Lee, ...
Neuron 103 (4), 627-641. e7, 2019
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
JL Gomez, J Bonaventura, W Lesniak, WB Mathews, P Sysa-Shah, ...
Science 357 (6350), 503-507, 2017
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
Autoimmune hypophysitis
P Caturegli, C Newschaffer, A Olivi, MG Pomper, PC Burger, NR Rose
Endocrine reviews 26 (5), 599-614, 2005
State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines
CM Dawidczyk, C Kim, JH Park, LM Russell, KH Lee, MG Pomper, ...
Journal of Controlled Release 187, 133-144, 2014
Diffusion tensor MR imaging of the brain and white matter tractography
ER Melhem, S Mori, G Mukundan, MA Kraut, MG Pomper, PCM van Zijl
American Journal of Roentgenology 178 (1), 3-16, 2002
Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
Z Szabo, E Mena, SP Rowe, D Plyku, R Nidal, MA Eisenberger, ...
Molecular imaging and biology 17, 565-574, 2015
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
YH Ko, BL Smith, Y Wang, MG Pomper, DA Rini, MS Torbenson, ...
Biochemical and biophysical research communications 324 (1), 269-275, 2004
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate …
Y Chen, M Pullambhatla, CA Foss, Y Byun, S Nimmagadda, ...
Clinical cancer research 17 (24), 7645-7653, 2011
Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer
SM Hillier, KP Maresca, FJ Femia, JC Marquis, CA Foss, N Nguyen, ...
Cancer research 69 (17), 6932-6940, 2009
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging
J Zhou, JO Blakeley, J Hua, M Kim, J Laterra, MG Pomper, PCM Van Zijl
Magnetic Resonance in Medicine: An Official Journal of the International …, 2008
Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging
S Mori, K Frederiksen, PCM Van Zijl, B Stieltjes, MA Kraut, M Solaiyappan, ...
Annals of Neurology: Official Journal of the American Neurological …, 2002
Amide proton transfer imaging of human brain tumors at 3T
CK Jones, MJ Schlosser, PCM Van Zijl, MG Pomper, X Golay, J Zhou
Magnetic Resonance in Medicine: An Official Journal of the International …, 2006
Routine clinical brain MRI sequences for use at 3.0 Tesla
H Lu, LM Nagae‐Poetscher, X Golay, D Lin, M Pomper, PCM Van Zijl
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2005
Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer
CA Foss, RC Mease, H Fan, Y Wang, HT Ravert, RF Dannals, ...
Clinical cancer research 11 (11), 4022-4028, 2005
Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner
Y Wang, J Seidel, BMW Tsui, JJ Vaquero, MG Pomper
Journal of Nuclear Medicine 47 (11), 1891-1900, 2006
Tissue Sodium Concentration in Human Brain Tumors as Measured with 23Na MR Imaging1
R Ouwerkerk, KB Bleich, JS Gillen, MG Pomper, PA Bottomley
Radiology 227 (2), 529-537, 2003
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic …
SY Cho, KL Gage, RC Mease, S Senthamizhchelvan, DP Holt, ...
Journal of Nuclear Medicine 53 (12), 1883-1891, 2012
Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)
SR Banerjee, CA Foss, M Castanares, RC Mease, Y Byun, JJ Fox, ...
Journal of medicinal chemistry 51 (15), 4504-4517, 2008
Bacteriolytic therapy can generate a potent immune response against experimental tumors
N Agrawal, C Bettegowda, I Cheong, JF Geschwind, CG Drake, ...
Proceedings of the National Academy of Sciences 101 (42), 15172-15177, 2004
The system can't perform the operation now. Try again later.
Articles 1–20